Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
treatment symbols : Hoth save search
Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment
Published: 2024-03-27 (Crawled : 00:00) - biospace.com/
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: 5.37%
H: 0.64%
C: -12.1%
obesity treatment wholly
Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZ
Published: 2024-03-19 (Crawled : 15:30) - biospace.com/
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: 21.74%
H: 19.29%
C: -3.57%
disease pre-clinical positive treatment alzheimer's therapeutics ht-alz study
FDA Grants Hoth Therapeutics Pre-IND Meeting for HT-KIT, Treatment for Cancer Patients
Published: 2023-10-02 (Crawled : 13:00) - biospace.com/
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: 5.9%
H: 0.0%
C: -7.45%
fda cancer treatment meeting grants therapeutics
Hoth Therapeutics Announces FDA Accepts Pre-Investigational New Drug (Pre-IND) Submission for HT-KIT, Treatment for Cancer Patients
Published: 2023-09-11 (Crawled : 14:00) - prnewswire.com
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: -0.81%
H: 16.39%
C: 11.07%
fda drug cancer treatment therapeutics submission
Hoth Therapeutics Announces Positive Preclinical End Point Results of HT-ALZ Treatment for Alzheimer's Disease
Published: 2023-08-09 (Crawled : 17:00) - biospace.com/
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: 8.89%
H: 2.04%
C: 2.04%
disease positive treatment preclinical alzheimer's therapeutics ht-alz results
Hoth Therapeutics Announces Positive Preclinical Results of HT-ALZ treatment for Alzheimer's Disease
Published: 2023-06-06 (Crawled : 15:00) - biospace.com/
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: 88.3%
H: 21.47%
C: -5.37%
disease positive treatment preclinical alzheimer's therapeutics ht-alz results
Hoth Therapeutics Announces FDA Acceptance of IND Application for HT-001 for the Treatment of Cancer Disorders Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy
Published: 2022-12-29 (Crawled : 14:00) - prnewswire.com
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: 102.05%
H: 40.61%
C: 20.58%
ht-001 treatment fda application therapeutics therapy cancer growth
Systemic Mastocytosis Treatments Gain Hope Due To Increasing Novel Treatment Options
Published: 2021-12-21 (Crawled : 14:00) - prnewswire.com
LGVN 1 d | $1.93 -3.98% -4.15% 460K
|
|
| O: 10.04%
H: 10.86%
C: 1.7%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.29%
H: 0.14%
C: 0.07%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.45%
H: 0.39%
C: -0.89%
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: 1.33%
H: 0.0%
C: -2.64%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.25%
H: 1.22%
C: 0.17%
treatment
Hoth Therapeutics Receives Approval to Commence Cohort 2 in Clinical Trial of BioLexa for the Treatment of Atopic Dermatitis Patients
Published: 2021-10-12 (Crawled : 14:00) - ir.hoththerapeutics.com
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: 0.0%
H: 12.17%
C: 0.87%
treatment dermatitis trial approval atopic dermatitis xin
Hoth Therapeutics Announces Positive Confirmatory Results from In Vivo Model of HT-003 Assets as Potential Treatment Against Acne
Published: 2021-07-13 (Crawled : 12:15) - ir.hoththerapeutics.com
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: 0.67%
H: 0.67%
C: -3.33%
treatment acne potential positive results
Hoth Therapeutics Announces Positive Safety Results from AD001 Cohort 1 of Phase 1b Clinical Trial of BioLexa for the Treatment of Atopic Dermatitis
Published: 2021-06-28 (Crawled : 12:00) - ir.hoththerapeutics.com
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: 1.26%
H: 4.97%
C: -1.86%
treatment phase 1 positive results dermatitis trial atopic dermatitis phase 1b al001 adi-001 phase 2b
Hoth Therapeutics' First in Human Clinical Trial for the Treatment of Atopic Dermatitis with BioLexa is Underway
Published: 2021-04-22 (Crawled : 14:00) - biospace.com/
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: 0.0%
H: 4.58%
C: -0.65%
treatment dermatitis trial atopic dermatitis
Hoth Therapeutics Completes Site Recruitment for Cohort 1 of First in Human Clinical Trial of BioLexa for the Treatment of Atopic Dermatitis
Published: 2021-03-01 (Crawled : 21:00) - biospace.com/
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: 0.0%
H: 5.02%
C: -1.7%
treatment dermatitis trial atopic dermatitis
Hoth Therapeutics Expands License Agreement to Include Innovative Cancer and Anaphylactic Treatment
Published: 2021-02-26 (Crawled : 16:12) - prnewswire.com
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: -0.86%
H: 17.39%
C: 2.17%
treatment cancer license
Hoth Therapeutics Expands Intellectual Property Portfolio with Novel Alzheimer's Treatment
Published: 2021-02-24 (Crawled : 18:00) - biospace.com/
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: -1.94%
H: 42.03%
C: 10.24%
alzheimer treatment therapeutics alzheimer’s alzheimer's
Hoth Therapeutics' HT-003 Shows Anti-inflammatory Benefits, Hoth to Expand Drug Development to Include Treatment of Inflammatory Bowel Diseases (IBDs)
Published: 2021-02-18 (Crawled : 19:00) - biospace.com/
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: 0.99%
H: 14.01%
C: -13.03%
disease treatment drug
Hoth Therapeutics Partners with Camargo Pharmaceutical Services for the HT-001 IND, a Treatment for Cancer Patients
Published: 2021-02-08 (Crawled : 20:09) - prnewswire.com
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: 2.92%
H: 0.36%
C: -2.43%
cancer treatment
Hoth Therapeutics Expands Research Collaboration Agreement with Weill Cornell Medicine to Continue the Advancement of HT-003 for Acne Treatment Research
Published: 2021-01-28 (Crawled : 15:00) - biospace.com/
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: 1.35%
H: 1.77%
C: -3.1%
collaboration treatment acne research
Hoth Therapeutics Announces Positive Initial Mechanism of Action Data for HT-003 In Pursuit for Acne Treatment Indication
Published: 2021-01-20 (Crawled : 14:08) - prnewswire.com
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: 6.98%
H: 2.17%
C: -2.61%
positive acne treatment
FDA Grants Hoth Therapeutics Pre-IND Meeting Regarding Proposed Drug Development Plan for HT-001 Treatment for Cancer Patients
Published: 2021-01-13 (Crawled : 15:00) - biospace.com/
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: 5.8%
H: 1.69%
C: -8.02%
cancer fda drug treatment granted grant
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.